Wednesday, 19 August 2015

Female Viagra Pill has been approved by FDA – with Restrictions.Details..

'Female Viagra' Flibanserin Approved by FDA with Restrictions

The Food and Drug Administration has approved flibanserin, the first drug in the United States aimed at treating low libido in women. The move follows a vigorous campaign by the drug's manufacturers. 
Though referred to as "female Viagra," the two drugs work in different ways. Viagra increases blood flow to the genitals, while flibanserin increases levels of neurotransmitters dopamine and norepinephrine in the brain. 
Because of these concerns, the FDA has placed a number of restrictions on the drug. The agency is asking flibanserin's maker, Sprout Pharmaceuticals, which is marketing the drug under the brand name Addyi, to develop and implement special training for doctors and pharmacists before they can dispense the drug. Once they have, they're required to carefully track problems that may develop in patients. 

No comments: